262 related articles for article (PubMed ID: 19287095)
1. The OTT-MAL fusion oncogene activates RBPJ-mediated transcription and induces acute megakaryoblastic leukemia in a knockin mouse model.
Mercher T; Raffel GD; Moore SA; Cornejo MG; Baudry-Bluteau D; Cagnard N; Jesneck JL; Pikman Y; Cullen D; Williams IR; Akashi K; Shigematsu H; Bourquin JP; Giovannini M; Vainchenker W; Levine RL; Lee BH; Bernard OA; Gilliland DG
J Clin Invest; 2009 Apr; 119(4):852-64. PubMed ID: 19287095
[TBL] [Abstract][Full Text] [Related]
2. [The OTT-MAL fusion oncogene: another Notch in megakaryoblastic leukemia].
Bernard OA; Gilliland DG; Mercher T
Med Sci (Paris); 2009; 25(8-9):676-8. PubMed ID: 19765378
[No Abstract] [Full Text] [Related]
3. Detection of RBM15-MKL1 fusion was useful for diagnosis and monitoring of minimal residual disease in infant acute megakaryoblastic leukemia.
Takeda A; Shimada A; Hamamoto K; Yoshino S; Nagai T; Fujii Y; Yamada M; Nakamura Y; Watanabe T; Watanabe Y; Yamamoto Y; Sakakibara K; Oda M; Morishima T
Acta Med Okayama; 2014; 68(2):119-23. PubMed ID: 24743787
[TBL] [Abstract][Full Text] [Related]
4. Fusion of OTT to BSAC results in aberrant up-regulation of transcriptional activity.
Sawada T; Nishiyama C; Kishi T; Sasazuki T; Komazawa-Sakon S; Xue X; Piao JH; Ogata H; Nakayama J; Taki T; Hayashi Y; Watanabe M; Yagita H; Okumura K; Nakano H
J Biol Chem; 2008 Sep; 283(39):26820-8. PubMed ID: 18667423
[TBL] [Abstract][Full Text] [Related]
5. JAK2T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model.
Mercher T; Wernig G; Moore SA; Levine RL; Gu TL; Fröhling S; Cullen D; Polakiewicz RD; Bernard OA; Boggon TJ; Lee BH; Gilliland DG
Blood; 2006 Oct; 108(8):2770-9. PubMed ID: 16804112
[TBL] [Abstract][Full Text] [Related]
6. c-Mpl-del, a c-Mpl alternative splicing isoform, promotes AMKL progression and chemoresistance.
Li F; Xiong Y; Yang M; Chen P; Zhang J; Wang Q; Xu M; Wang Y; He Z; Zhao X; Huang J; Gu X; Zhang L; Sun R; Sun X; Li J; Ou J; Xu T; Huang X; Cao Y; Xu XR; Karakas D; Li J; Ni H; Zhang Q
Cell Death Dis; 2022 Oct; 13(10):869. PubMed ID: 36229456
[TBL] [Abstract][Full Text] [Related]
7. Pediatric Acute Megakaryoblastic Leukemia: Multitasking Fusion Proteins and Oncogenic Cooperations.
Lopez CK; Malinge S; Gaudry M; Bernard OA; Mercher T
Trends Cancer; 2017 Sep; 3(9):631-642. PubMed ID: 28867167
[TBL] [Abstract][Full Text] [Related]
8. RBM15-MKL1 (OTT-MAL) fusion transcript in an adult acute myeloid leukemia patient.
Hsiao HH; Yang MY; Liu YC; Hsiao HP; Tseng SB; Chao MC; Liu TC; Lin SF
Am J Hematol; 2005 May; 79(1):43-5. PubMed ID: 15849773
[TBL] [Abstract][Full Text] [Related]
9. Human models of NUP98-KDM5A megakaryocytic leukemia in mice contribute to uncovering new biomarkers and therapeutic vulnerabilities.
Cardin S; Bilodeau M; Roussy M; Aubert L; Milan T; Jouan L; Rouette A; Laramée L; Gendron P; Duchaine J; Decaluwe H; Spinella JF; Mourad S; Couture F; Sinnett D; Haddad É; Landry JR; Ma J; Humphries RK; Roux PP; Hébert J; Gruber TA; Wilhelm BT; Cellot S
Blood Adv; 2019 Nov; 3(21):3307-3321. PubMed ID: 31698461
[TBL] [Abstract][Full Text] [Related]
10. Acute megakaryoblastic leukemia with a four-way variant translocation originating the RBM15-MKL1 fusion gene.
Torres L; Lisboa S; Vieira J; Cerveira N; Santos J; Pinheiro M; Correia C; Bizarro S; Almeida M; Teixeira MR
Pediatr Blood Cancer; 2011 May; 56(5):846-9. PubMed ID: 21370421
[TBL] [Abstract][Full Text] [Related]
11. A case of
Forlenza CJ; Zhang Y; Yao J; Benayed R; Steinherz P; Ramaswamy K; Kessel R; Roshal M; Shukla N
Cold Spring Harb Mol Case Stud; 2018 Dec; 4(6):. PubMed ID: 30455225
[TBL] [Abstract][Full Text] [Related]
12. The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesis.
Alejo-Valle O; Weigert K; Bhayadia R; Ng M; Issa H; Beyer C; Emmrich S; Schuschel K; Ihling C; Sinz A; Zimmermann M; Wickenhauser C; Flasinski M; Regenyi E; Labuhn M; Reinhardt D; Yaspo ML; Heckl D; Klusmann JH
Blood; 2022 Feb; 139(5):651-665. PubMed ID: 34570885
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of OTT-MAL fusion in t(1;22) of infant AML-M7.
Mercher T; Busson-Le Coniat M; Nguyen Khac F; Ballerini P; Mauchauffé M; Bui H; Pellegrino B; Radford I; Valensi F; Mugneret F; Dastugue N; Bernard OA; Berger R
Genes Chromosomes Cancer; 2002 Jan; 33(1):22-8. PubMed ID: 11746984
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
[TBL] [Abstract][Full Text] [Related]
15. CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax.
Neault M; Lebert-Ghali CÉ; Fournier M; Capdevielle C; Garfinkle EAR; Obermayer A; Cotton A; Boulay K; Sawchyn C; St-Amand S; Nguyen KH; Assaf B; Mercier FE; Delisle JS; Drobetsky EA; Hulea L; Shaw TI; Zuber J; Gruber TA; Melichar HJ; Mallette FA
Cell Rep; 2023 Sep; 42(9):113084. PubMed ID: 37716355
[TBL] [Abstract][Full Text] [Related]
16. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
[TBL] [Abstract][Full Text] [Related]
17. AKT collaborates with ERG and Gata1s to dysregulate megakaryopoiesis and promote AMKL.
Stankiewicz MJ; Crispino JD
Leukemia; 2013 Jun; 27(6):1339-47. PubMed ID: 23380710
[TBL] [Abstract][Full Text] [Related]
18. Acute megakaryoblastic leukaemia with t(1;22)(p13·3;q13·1)/RBM15-MKL1 in an adult patient following a non-mediastinal germ cell tumour.
Saito Y; Makita S; Chinen S; Kito M; Fujino T; Ida H; Hosoba R; Tanaka T; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Miyagi-Maeshima A; Matsushita H; Izutsu K
Br J Haematol; 2020 Sep; 190(6):e329-e332. PubMed ID: 32572949
[No Abstract] [Full Text] [Related]
19. Characterization of novel genomic alterations and therapeutic approaches using acute megakaryoblastic leukemia xenograft models.
Thiollier C; Lopez CK; Gerby B; Ignacimouttou C; Poglio S; Duffourd Y; Guégan J; Rivera-Munoz P; Bluteau O; Mabialah V; Diop M; Wen Q; Petit A; Bauchet AL; Reinhardt D; Bornhauser B; Gautheret D; Lecluse Y; Landman-Parker J; Radford I; Vainchenker W; Dastugue N; de Botton S; Dessen P; Bourquin JP; Crispino JD; Ballerini P; Bernard OA; Pflumio F; Mercher T
J Exp Med; 2012 Oct; 209(11):2017-31. PubMed ID: 23045605
[TBL] [Abstract][Full Text] [Related]
20. Acute megakaryoblastic leukemia in a child with the MLL-AF4 fusion gene.
Takita J; Motomura A; Koh K; Ida K; Taki T; Hayashi Y; Igarashi T
Eur J Haematol; 2009 Aug; 83(2):149-53. PubMed ID: 19459927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
